Company fully deploys 2021 work
Release time:
2021-02-10
Summing up Experience, Finding Problems, Formulating Measures
Company Fully Deploys 2021 Work
This newspaper reported that on February 1 and 2, the Group Company held a business work analysis meeting to review and summarize the work situation in 2020, arrange the deployment of the work for the new year, and put forward work requirements. At the
meeting, various professional companies and directly affiliated enterprises made reports on the overall work situation in 2020, focusing on analyzing the existing problems and deficiencies, and proposing corresponding solutions and work plans for 2021. The functional departments and offices of the headquarters made a brief report on the annual work situation and the 2021 work plan. Xiang Chongping, deputy general manager of the group company, systematically combed the current human resources efficiency and human resources development of the company. Lan Xiaolong, head of finance, analyzed the risks and challenges currently faced by the company according to the operating data and financial situation of each subordinate enterprise. Chen Tianci, chairman of the board of supervisors, made a report and analysis on the internal control management and bidding management in 2020; zhu Jianwei, Secretary of the Board of Directors, analyzed the future risks that the Company may encounter from the perspective of the securities market trends of listed companies in peak and related industries in 2020. Yu Jianhong, general manager of
Group Company, made a comprehensive review of the company's operation in 2020, made a comparative analysis of the main economic indicators of various industrial sectors, and pointed out that actively responding to the new coronary pneumonia epidemic has ensured the safety and health of all employees, made substantial progress in the construction of key investment projects, continuously strengthened management integration and improved management level, made new achievements in scientific and technological innovation and technological transformation, and made efforts to overcome the impact of expanding sales, innovative talent training, selection, and introduction forms, and effective improvement of corporate image, influence and reputation; at the same time, there is insufficient motivation for innovation and change, and the ideas and thinking methods of managers are still relatively traditional, conservative, and lack of pioneering spirit and crisis awareness. The gap between the comprehensive strength of the two main businesses and the competitiveness of some products and advanced enterprises in the industry is increasing, and the ability to develop new products is weak, the application of digital and intelligent technology is backward, and the work has some shortcomings such as superficial and formal phenomena to summarize and reflect.
After analyzing the current macroeconomic situation and the future trends of various related industries, Yu Jianhong notified the 2021 benefit target set by the group company to various professional companies and directly affiliated enterprises, and proposed to follow the market law trend, achieve "five persistence", and fundamentally reverse the ideological concept of management cadres; Do a good job in project management, cultivate industrial advantages, and steadily promote development; Optimize the management system, strengthen management improvement and improve management efficiency; further strengthen technological innovation, increase investment in technological transformation, and promote the construction of "digital intelligence factory"; respect market laws, pay attention to user needs, and improve marketing capabilities; do a good job in management team building and further strengthen human resource development; Promote safety and environmental protection management to a new level; take party building as the guide, strengthen ideological and political work, enrich corporate cultural connotations, and create "soft power" for corporate competition "; we will continue to do a good job in the normal management of the prevention and control of the new crown pneumonia epidemic. In his concluding speech, Jiang Xiaomeng, chairman of
Group Company, expressed his affirmation and gratitude to all enterprises for their efforts and achievements in 2020. For future work, he asked the heads of subordinate enterprises to earnestly understand the spirit of the meeting, form a consensus, fully implement the company's various work arrangements and effectively promote them. Managers at all levels should strive to improve their ability to adapt to the changes of the times and achieve "the ability to find problems, there are ways to solve problems"; Establish a "3 3 N" way of thinking, that is, do a good job in the current work of sales, cost reduction, safety and environmental protection, plan the future development of forward-looking industrial layout, excellent products with market competitiveness, and capable excellent teams, and do a good job in the "N" related to the two "3; achieve both" visible management "such as labor discipline and work site and" invisible management "such as decision-making ability, charisma, and planning ability, so as to make enterprise management work smoother. Jiang Xiaomeng also hopes that all enterprises will increase the training and use of young backbones, better improve the combat effectiveness and work passion of the team, and all cadres and employees will work together to promote the better development of enterprises. (Reporter Fu Yiwu)
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11